|
Treatment Study
|
NCIT_C49656 |
|
|
protocol
|
OBI_0000272 |
|
|
Prevention Study
|
NCIT_C49657 |
|
|
Clinical Study Protocol
|
NCIT_C25320 |
|
|
Study Protocol
|
NCIT_C70817 |
|
|
Diagnosis Study
|
NCIT_C49653 |
|
|
drug administration
|
OAE_0000011 |
|
|
Study Condition
|
NCIT_C93360 |
|
|
Personal Attribute
|
NCIT_C19332 |
|
|
disease
|
OGMS_0000031 |
|
|
disposition
|
BFO_0000016 |
|
|
Device Feasibility Study
|
NCIT_C139174 |
|
|
value specification
|
OBI_0001933 |
|
|
adverse event
|
OAE_0000001 |
|
|
pathological bodily process
|
OGMS_0000061 |
|
|
Condition or Disease under Study
|
NCIT_C161319 |
|
|
medical condition
|
OPMI_0000282 |
|
|
centrally registered identifier
|
IAO_0000578 |
|
|
registry
|
ERO_0001843 |
|
|
organization
|
OBI_0000245 |
|
